OnKure Therapeutics OKUR
NASDAQ OKUR
$3.94 +0.01 (+0.25%)
At close: Aug 21, 2026 · 4:00 PM EDT

OnKure Therapeutics (OKUR) Prepaid Assets (2020 - 2026)

OnKure Therapeutics' (OKUR) quarterly Prepaid Assets came in at $5.4 million in Q1 2026, up 255.79% YoY from $1.5 million in Q1 2025, and up 200.5% on a QoQ basis from $1.8 million in Q4 2025.

OnKure Therapeutics (OKUR) Prepaid Assets (2020 - 2026) Analysis & Trends

OnKure Therapeutics (OKUR) has 7 years of Prepaid Assets data on file, last reported at $5.4 million in Q1 2026.

  • Quarterly Prepaid Assets rose 255.79% year-over-year to $5.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.4 million (up 255.79% YoY) and the FY2025 annual result came in at $1.8 million, down 20.21% from the prior year.
  • Prepaid Assets climbed to $5.4 million in Q1 2026, from $1.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $5.4 million in Q1 2026 to a low of $331000.0 in Q3 2024.
  • A 5-year average of $2.9 million and a median of $3.2 million in 2023 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets tumbled 89.52% — and 2025, when it jumped 261.03%.
  • Tracing OKUR's Prepaid Assets over 5 years: stood at $5.2 million in 2022, then dropped by 24.9% to $3.9 million in 2023, then sank by 42.37% to $2.2 million in 2024, then fell by 20.21% to $1.8 million in 2025, then surged by 200.5% to $5.4 million in 2026.
  • The last three Prepaid Assets figures came in at $5.4 million (Q1 2026), $1.8 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 OnKure Therapeutics 195.74 Mn 19.35 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.29 Mn
Mar 31, 2026 5.38 Mn
Dec 31, 2025 1.79 Mn
Sep 30, 2025 1.20 Mn
Jun 30, 2025 1.18 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 2.24 Mn
Sep 30, 2024 331,000.00
Jun 30, 2024 1.32 Mn
Mar 31, 2024 1.09 Mn
Dec 31, 2023 3.89 Mn
Sep 30, 2023 3.16 Mn
Jun 30, 2023 3.64 Mn
Mar 31, 2023 3.23 Mn
Dec 31, 2022 5.18 Mn
Sep 30, 2022 4.92 Mn
Jun 30, 2022 5.16 Mn
Mar 31, 2022 4.05 Mn
Dec 31, 2021 6.06 Mn
Sep 30, 2021 4.93 Mn